There is no single “best” antibiotic for pneumonia because the right choice depends on where the infection was caught, what type of bacteria is causing it, and whether you have other health conditions. For otherwise healthy adults with community-acquired pneumonia (the most common type), amoxicillin, azithromycin, and doxycycline are the standard first-line treatments. Each works well for mild to moderate cases, and your doctor will choose based on your specific situation.
Antibiotics for Mild Pneumonia in Healthy Adults
Most people who develop pneumonia pick it up in everyday life, not in a hospital. This is called community-acquired pneumonia, and if you’re generally healthy with no chronic lung disease, heart failure, or immune problems, the antibiotic options are straightforward.
The joint guidelines from the American Thoracic Society and the Infectious Diseases Society of America recommend two main choices for this group. The first is a macrolide antibiotic, with azithromycin being the most commonly prescribed. It’s typically taken as 500 mg on the first day, then 250 mg daily for four more days, making it a short and convenient course. Clarithromycin is another macrolide option, taken at 500 mg twice daily. The second option is doxycycline, usually 100 mg twice daily. Doxycycline is considered a slightly weaker recommendation based on available evidence, but it remains a solid alternative, especially for people who can’t tolerate macrolides.
Amoxicillin, at a higher dose of 1,000 mg three times daily, is another widely used first-line choice. It’s particularly effective against the most common bacterial cause of pneumonia and is often preferred in clinical practice outside the United States, including Canadian and British guidelines.
When Pneumonia Is More Complicated
If you have chronic health conditions like heart disease, diabetes, chronic lung disease, or a weakened immune system, standard first-line antibiotics may not be enough on their own. In these cases, doctors typically use combination therapy or choose a broader-spectrum antibiotic that covers a wider range of bacteria.
Respiratory fluoroquinolones (levofloxacin and moxifloxacin) are effective against pneumonia, but they come with serious safety concerns. The FDA has issued multiple warnings about these drugs, starting with a black box warning in 2008 linking them to tendinitis and tendon rupture. In 2013, the FDA added a warning about irreversible peripheral neuropathy, which causes numbness, weakness, and pain in the hands and feet. Additional warnings have followed for mental health side effects, blood sugar disturbances, and a risk of aortic aneurysm. Because of these risks, fluoroquinolones are generally reserved for situations where safer antibiotics aren’t appropriate.
Hospital-Acquired Pneumonia Requires Stronger Coverage
Pneumonia that develops during or after a hospital stay is a different challenge entirely. The bacteria involved are often resistant to common antibiotics, which means treatment needs to be more aggressive. Doctors choose antibiotics based on local resistance patterns tracked through hospital-specific data called an antibiogram, which shows which bacteria in that facility respond to which drugs.
The key concern with hospital-acquired pneumonia is whether the infection involves drug-resistant organisms like MRSA or Pseudomonas. When these bacteria are suspected, broader and more powerful antibiotics are needed, often given through an IV. For patients without risk factors for resistant bacteria, treatment can be narrower and simpler. The overall goal is to use the most targeted antibiotic possible to avoid fueling further resistance.
Aspiration Pneumonia
Aspiration pneumonia occurs when food, liquid, or saliva is inhaled into the lungs, often in people with swallowing difficulties, neurological conditions, or after heavy sedation. There’s a longstanding assumption that this type of pneumonia requires antibiotics that specifically target anaerobic bacteria (the kind that thrive without oxygen). However, current evidence published in the journal CHEST suggests that standard community-acquired pneumonia antibiotics like ceftriaxone work well without adding extra anaerobic coverage. Adding drugs like clindamycin or metronidazole on top of first-line treatment doesn’t appear to improve outcomes and may cause unnecessary side effects.
Pneumonia Treatment in Children
For children, amoxicillin is the go-to antibiotic for bacterial pneumonia across all age groups. It’s effective, well-tolerated, and comes in liquid form for younger kids. When an atypical bacterial cause is suspected (common in school-aged children and often producing a persistent dry cough), azithromycin is the preferred choice.
For children who need to be hospitalized, guidelines recommend narrow-spectrum antibiotics like ampicillin or penicillin rather than broader options. This is an important distinction: broader antibiotics like ceftriaxone are reserved for children who aren’t fully vaccinated against common pneumonia-causing bacteria. The push toward narrower treatment helps preserve antibiotic effectiveness and reduces side effects.
How Long Treatment Typically Takes
Most mild to moderate pneumonia in adults is treated with a 5 to 7 day course of antibiotics, though this can vary. Azithromycin’s standard course is just 5 days. Amoxicillin and doxycycline are usually taken for 5 to 7 days. You should start feeling noticeably better within 2 to 3 days of starting treatment. Fever often resolves first, followed by gradual improvement in cough and energy levels. Full recovery of lung function and energy can take several weeks even after the infection itself is cleared.
If your symptoms aren’t improving after 48 to 72 hours on antibiotics, that’s a signal to follow up with your doctor. The initial antibiotic may not be covering the specific bacteria causing your infection, and a switch or additional testing may be needed.
Why There’s No Universal “Best” Antibiotic
Pneumonia can be caused by dozens of different bacteria, viruses, and even fungi. Antibiotics only work against bacterial pneumonia, and different bacteria respond to different drugs. The bacterium most commonly responsible for community-acquired pneumonia (Streptococcus pneumoniae) responds well to amoxicillin and macrolides. But atypical bacteria like Mycoplasma respond better to azithromycin or doxycycline. Hospital-acquired infections often involve resistant organisms that require entirely different classes of drugs.
In practice, most pneumonia is treated empirically, meaning the doctor chooses an antibiotic based on the most likely cause given your symptoms, health history, and where you got sick, without waiting for lab results to confirm the exact bacterium. This is why the guidelines focus on categories of patients rather than specific bacteria. If a sputum culture or other test identifies the organism, treatment can be narrowed to the most targeted antibiotic available.